Novo Nordisk A/S Share | Buy US Stock from India on Kuvera

Q: Can I buy Novo Nordisk A/S shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Novo Nordisk A/S stocks after a simple registration process. </div>

Q: How to buy Novo Nordisk A/S shares in India?

<div> To buy Novo Nordisk A/S shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Novo Nordisk A/S and you are done!</div> </div>

Q: What is the share price of Novo Nordisk A/S?

<div>The share price of Novo Nordisk A/S is USD 108.84 as on 18 Dec.</div>

Q: What is the Market Capitalization of Novo Nordisk A/S?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Novo Nordisk A/S is USD 366.66B as on 18 Dec.</div>

Q: What is the PE ratio of Novo Nordisk A/S?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Novo Nordisk A/S is 34.03 as on 18 Dec. </div>

Q: Is Novo Nordisk A/S a good stock to buy?

<div>Kuvera provides relevant fundamental details of Novo Nordisk A/S to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Novo Nordisk A/S operate?

<div> Novo Nordisk A/S operates in Healthcare / Biotechnology

Healthcare Biotechnology

$108.84

+0.82

(7:23 pm IST)

Loading Chart

Previous close

$108.84

Open

$108.84

Today’s high

$109.04

Today’s low

$107.13

52W low

$99.42

52W high

$147.593

9.93%

30.76%

34.03

Div yield

1.42%

EPS (TTM)

2.99

Shares O/S

3.37B

Market cap

366.66B

Insights

NVO price is above its 200 day moving average

In beta. Send feedback here.

Compare with other stock

About Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs.

The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations. .

FAQs

Can I buy Novo Nordisk A/S shares in India?

How to buy Novo Nordisk A/S shares in India?

What is the share price of Novo Nordisk A/S?

What is the Market Capitalization of Novo Nordisk A/S?

What is the PE ratio of Novo Nordisk A/S?

Is Novo Nordisk A/S a good stock to buy?

In which sector / industry does Novo Nordisk A/S operate?